Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$755,311
-$87,313 QoQ
Shares Held
1,394
-1.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#503
of 870 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $2,556,716 across 7 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,394 | $755,311 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
3,229 | $544,215 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
16,383 | $403,185 | |
| 4 | ALKS |
Alkermes plc.
|
4,793 | $251,153 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
2,186 | $242,514 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
6,782 | $235,131 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
25,397 | $125,207 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $755,311 | 1,394 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $842,624 | 1,421 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $692,382 | 1,421 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $670,316 | 1,599 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $459,472 | 1,599 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $500,630 | 1,624 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $592,418 | 1,679 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $618,512 | 1,726 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $549,817 | 1,726 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $464,953 | 2,024 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $445,057 | 2,024 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $507,304 | 2,246 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $495,804 | 2,246 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $518,019 | 2,313 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $643,222 | 2,313 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $498,115 | 2,379 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $560,587 | 2,379 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $426,816 | 2,379 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $514,054 | 2,379 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $454,620 | 2,463 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $441,886 | 2,463 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $411,986 | 2,463 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $387,975 | 2,556 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $258,156 | 2,556 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $309,276 | 2,556 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $262,679 | 2,770 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||